Search

Search Constraints

You searched for: Author/Creator Ringelhan, Marc

Search Results

1. Canonical NF‐κB signaling in hepatocytes acts as a tumor‐suppressor in hepatitis B virus surface antigen‐driven hepatocellular carcinoma by controlling the unfolded protein response. Issue 5 (4th March 2016)

4. Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus Infection. (25th December 2019)

5. Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane. (22nd November 2021)

6. Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20. (9th May 2021)

7. Modeling Human Liver Cancer Heterogeneity: Virally Induced Transgenic Models and Mouse Genetic Models of Chronic Liver Inflammation. Issue 1 (1st December 2014)

8. Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection. Issue 10 (26th June 2020)

9. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells12. Issue 6 (12th June 2013)

10. Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination. (3rd August 2017)